Secretory phospholipase A

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages

  De Luca, Daniele ^a,b   Minucci, Angelo ^b   Cogo, Paola ^a   Capoluongo, Ettore D ^b   Conti, Giorgio ^c   Pietrini, Domenico ^b   Carnielli, Virgilio P ^c   Piastra, Marco ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

acute respiratory distress syndrome; bronchiolitis; infants; phospholipase A2

Indexed keywords

SECRETORY PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INFANT; INTENSIVE CARE UNIT; ITALY; LUNG LAVAGE; MALE; METABOLISM; MULTICENTER STUDY; PILOT STUDY; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY; ARTIFICIAL VENTILATION; CHILDHOOD DISEASE; CLINICAL ARTICLE; ENZYME ACTIVITY; HOSPITALIZATION; LENGTH OF STAY; LUNG DISEASE; LUNG EMPHYSEMA; OXYGEN SATURATION; OXYGENATION; PNEUMOMEDIASTINUM; PNEUMOTHORAX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

BRONCHOALVEOLAR LAVAGE; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; ITALY; MALE; PHOSPHOLIPASES A2, SECRETORY; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751642835     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181dbe95e     Document Type: Article

References (29)

1. Hallstrand TS, Chi EY, Singer AG, et al: Secreted phospholipase A2 Group X overexpression in asthma and bronchial hyperresponsiveness. Am J Resp Crit Care Med 2007; 176:1072-1078
2. Sippola T, Aho H, Peuravuori H, et al: Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr Res 2006; 59:641-645
3. Nakos G, Kitsiouli E, Hatzidaki E, et al: Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:772-779
4. Touqui L, Arbibe L: A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999; 5:244-249
5. Hurley BP, McCormick BA: Multiple roles of phospholipase A2 during lung infection and inflammation. Infect Immun 2008; 76:2259-2272
6. Yoshikawa S, Miyahara T, Reynolds SD, et al: Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice. J Appl Physiol 2005; 98:1264-1271
7. De Luca D, Minucci A, Zecca E, et al: Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med 2009; 35:321-326
8. Jorens PG, Sibille Y, Goulding NJ, et al: Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8:1647-1653
9. Broeckaert F, Clippe A, Knoops B, et al: Clara cell secretory protein (CC16): Features as a peripheral lung biomarker. Ann N Y Acad Sci 2000; 923:68-77
10. Ramsay PL, DeMayo FJ, Hegemier SE, et al: Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary displasia. Am J Respir Crit Care Med 2001; 164:155-161
11. Liu T, Zaman W, Kaphalia BS, et al: RSV-induced prostaglandin E2 production occurs via cPLA2 activation: Role in viral replication. Virology 2005; 343:12-24
12. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis: Diagnosis and management of bronchiolitis. Pediatrics 2006; 118:1774-1793
13. Piastra M, Caresta E, Tempera A, et al: Sharing features of uncommon respiratory syncytial virus complications in infants. Pediatr Emerg Care 2006; 22:574-578
14. Hammer J, Numa A, Newth CJL: Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol 1997; 23:176-183
15. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
16. de Blic J, Midulla F, Barbato A, et al: Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000; 15:217-231
17. De Luca D, Baroni S, Vento G, et al: Secretory phospholipase A2 and neonatal respiratory distress: Pilot study on broncho-alveolar lavage. Intensive Care Med 2008; 34:1858-1864
18. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
19. Reynolds LJ, Hughes LL, Tennis EA: Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: Development of a spectrophotometric assay suitable for a microtiterplate reader. Anal Biochem 1992; 204:190-197
20. Chard T: An Introduction to Radioimmunoassay and Related Techniques. Fourth Edition. Amsterdam, Elsevier, 1990
21. Benson M, Jansson L, Adner M, et al: Gene profiling, reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis. Clin Exp Allergy 2005; 35:473-484
22. Capoluongo E, Ameglio F, Lulli P, et al: Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol Metab 2007; 292:E308-E313
23. Kitsiouli E, Nakos G, Lekka ME: Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 2009; 1792:941-953
24. Arbibe L, Vial D, Rosinski-Chupin I, et al: Endotoxin induces expression of type II phospholipase A2 during acute lung injury in guinea pigs: Involvement of TNF-a in lipopolysaccharide-induced type-II phospholipase A2 synthesis. J Immunol 1997; 159:391-400
25. Todd DA, Marsh MJ, George A, et al: Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children. Pediatr Crit Care Med 2010; 11:82-91
26. Balboa MA, Perez R, Balsinde J: Amplification mechanisms of inflammation: Paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A2 is regulated by cytosolic phospholipase A2-derived hydroperoxyeicosatetraenoic acid. J Immunol 2003; 171:989-994
27. Han WK, Sapirstein SA, Hung CC, et al: Cross talk between cytosolic phospholipase A2alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells. J Biol Chem 2003; 278:24153-24163
28. Ackerman SJ, Kwatia MA, Doyle CB, et al: Hydrolysis of surfactant phospholipids catalyzed by phospholipase A2 and eosinophil lysophospholipases causes surfactant dysfunction. Chest 2003; 123:355S
29. De Luca D, Baroni S, Vento G, et al: Secretory phospholipase A2 and neonatal respiratory distress: Pilot study on broncho-alveolar lavage. Intensive Care Med 2008; 34:1858-1864